M&A Deal Summary |
|
|---|---|
| Date | 2014-04-02 |
| Target | Synchrogenix Information Strategies |
| Sector | Medical Products |
| Buyer(s) | Certara |
| Deal Type | Add-on Acquisition |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 2008 |
| Sector | Life Science |
| Employees | 1,487 |
| Revenue | 385M USD (2024) |
Certara engages in model-informed drug development and regulatory science, focused on optimizing drug development and improving health outcomes. Certara was founded in 2008 and is headquartered in Princeton, New Jersey.
| DEAL STATS | # |
|---|---|
| Overall | 2 of 11 |
| Sector: Medical Products M&A | 1 of 1 |
| Type: Add-on Acquisition M&A Deals | 2 of 11 |
| State: Delaware M&A | 1 of 1 |
| Country: United States M&A | 2 of 6 |
| Year: 2014 M&A | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2013-08-12 |
Great Lakes Drug Development
Brighton, Michigan, United States Great Lakes Drug Development, Inc. is a provider of strategic, operational and interim management support for early drug development projects. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2015-12-01 |
XenologiQ
Canterbury, United Kingdom XenologiQ is a quantitative systems pharmacology (QSP) consultancy provider. |
Buy | - |